Tue, Feb 24, 2026
Viren Laljbhai Vaghasiya1 
, Divya D Bambhaniya2 , Jitendra Gordhanbhai Nasit2 , Bhoomika H Rupavatiya2
, Divya D Bambhaniya2 , Jitendra Gordhanbhai Nasit2 , Bhoomika H Rupavatiya2
1- Medical College Baroda, the Maharaja Sayajirao University of Baroda, Vadodara, Gujarat, India , Viren.vaghasiya-path@msubaroda.ac.in
2- Medical College Baroda, the Maharaja Sayajirao University of Baroda, Vadodara, Gujarat, India
2- Medical College Baroda, the Maharaja Sayajirao University of Baroda, Vadodara, Gujarat, India
Abstract: (1309 Views)
Background: Sickle cell disease is a hemoglobinopathy caused by a point mutation and has a heterogeneous clinical course. The level of Hb F within erythrocytes is believed to be the most important parameter determining disease severity. The aim of this study was to investigate whether Hb F level, F-cell count, and sickle cell percentage after in vitro induction of sickling can predict the severity of the disease.
Methods: All necessary data were collected from clinical history, biochemistry, and pathology laboratory tests. This was a cross-sectional study with 31 participants. Statistical analyses were performed using the correlation coefficient and chi-square test to identify significant differences between variables. Statistical analysis was performed using MedCalc software.
Results: The majority of patients fell into the mild severity score category, with a lack of severe disease phenotypes. The number of painful episodes, hospitalizations, and cumulative disease severity scores were associated with high levels of LDH and indirect bilirubin. However, none of the clinical disease severity parameters or the overall cumulative disease severity score was associated with Hb F level, F-cell count, or the percentage of sickled cells after in vitro induction of sickling. A high percentage of F-cells was associated with high MCV, MCH, and MCHC and low RDW, LDH, and indirect bilirubin levels.
Conclusion: Sickle cell disease severity is related to the susceptibility of RBCs to hemolysis, as indicated by serum LDH and indirect bilirubin levels. However, the extent of hemolysis may depend on multiple factors rather than F-cell count or Hb F level alone.
Methods: All necessary data were collected from clinical history, biochemistry, and pathology laboratory tests. This was a cross-sectional study with 31 participants. Statistical analyses were performed using the correlation coefficient and chi-square test to identify significant differences between variables. Statistical analysis was performed using MedCalc software.
Results: The majority of patients fell into the mild severity score category, with a lack of severe disease phenotypes. The number of painful episodes, hospitalizations, and cumulative disease severity scores were associated with high levels of LDH and indirect bilirubin. However, none of the clinical disease severity parameters or the overall cumulative disease severity score was associated with Hb F level, F-cell count, or the percentage of sickled cells after in vitro induction of sickling. A high percentage of F-cells was associated with high MCV, MCH, and MCHC and low RDW, LDH, and indirect bilirubin levels.
Conclusion: Sickle cell disease severity is related to the susceptibility of RBCs to hemolysis, as indicated by serum LDH and indirect bilirubin levels. However, the extent of hemolysis may depend on multiple factors rather than F-cell count or Hb F level alone.
Research Article: Research Article |
Subject:
Laboratory hematology
Received: 2024/02/17 | Accepted: 2024/05/20
Received: 2024/02/17 | Accepted: 2024/05/20
References
1. Ashwin PP, Madhuben RN, Nilam MS, Narmadeshwar PS, Prakash HP. Prevalence of common hemoglobinopathies in Gujarat: an analysis of a large population screening program. Natl J Community Med. 2012; 3:112-7. [View at Publisher] [Google Scholar]
2. Jain D, Mohanty D. Clinical manifestations of sickle cell disease in India: misconceptions and reality. Curr Opin Hematol. 2018;25(3):171-6. [View at Publisher] [DOI] [PMID] [Google Scholar]
3. Steinberg MH, Chui DH, Dover GJ, Sebastiani P, Alsultan A. Fetal hemoglobin in sickle cell anemia: a glass half full? Blood. 2014;123(4):481-5. [View at Publisher] [DOI] [PMID] [Google Scholar]
4. Estepp JH, Smeltzer MP, Kang G, Li C, Wang WC, Abrams C, et al. A clinically meaningful fetal hemoglobin threshold for children with sickle cell anemia during hydroxyurea therapy. Am J Hematol. 2017;92(12):1333-9 [View at Publisher] [DOI] [PMID] [Google Scholar]
5. Hebert N, Rakotoson MG, Bodivit G, Audureau E, Bencheikh L, Kiger L, et al. Fetal hemoglobin quantification per red blood cell allows to determine protective thresholds in sickle cell disease. Am J Hematol. 2020;95(11):1235-45. [View at Publisher] [DOI] [PMID] [Google Scholar]
6. Adegoke SA, Kuti BP. Evaluation of clinical severity of sickle cell anemia in Nigerian children. J App Hematol. 2013;4(2):58-64. [View at Publisher] [Google Scholar]
7. Oyenike MA, Akpan HB, Otulana OJ, Adefule AK, Adedokun KA, Oluogun WA, et al. In-vitro anti-sickling and membrane stability potentials of Mishenland polyherbal extract on sickle red blood cells. Egypt J Haematol. 2019;44(1):65-71. [View at Publisher] [DOI] [Google Scholar]
8. Okocha E, Onwubuya E, Osuji C, Ahaneku G, Okonkwo U, Ibeh N, et al. Disease severity scores and haemogram parameters in Nigerian sickle cell disease patients. J Blood Disord Transfus. 2015;6(6):1-5. [View at Publisher] [DOI] [Google Scholar]
9. Powars DR, Schroeder WA, Weiss JN, Chan LS, Azen SP. Lack of influence of fetal hemoglobin levels or erythrocyte indices on the severity of sickle cell anemia. J Clin Invest. 1980;65(3):732-40 [View at Publisher] [DOI] [PMID] [Google Scholar]
10. Ozsoylu S, Altinöz N. Sickle-cell anaemia in Turkey. Evaluation of 97 cases (with parents' findings). Scand J Haematol. 1977;19(1):85-92. [View at Publisher] [DOI] [PMID] [Google Scholar]
11. Serjeant GR, Richards R, Barbor PR, Milner PF. Relatively benign sickle-cell anaemia in 60 patients aged over 30 in the West Indies. Br Med J. 1968;3(5610):86-91. [View at Publisher] [DOI] [PMID] [Google Scholar]
12. Ali SA. Milder variant of sickle‐cell disease in Arabs in Kuwait associated with unusually high level of foetal haemoglobin. Br J Haematol. 1970;19(5):613-9. [View at Publisher] [DOI] [PMID] [Google Scholar]
13. Haghshenass M, Ismail-Beigi F, Clegg JB, Weatherall DJ. Mild sickle-cell anaemia in Iran associated with high levels of fetal haemoglobin. J Med Geneti. 1977;14(3):168-71. [View at Publisher] [DOI] [PMID] [Google Scholar]
14. Gelpi AP. Sickle cell disease in Saudi Arabs. Acta Haematol. 1970;43(2):89-99. [View at Publisher] [DOI] [PMID] [Google Scholar]
15. Perrine RP, Brown MJ, Clegg JB, Weatherall DJ, May A. Benign sickle-cell anaemia. Lancet. 1972;2(7788):1163-7. [View at Publisher] [DOI] [PMID] [Google Scholar]
16. Perrine RP, Pembrey ME, John P, Perrine S, Shoup F. Natural history of sickle cell anemia in Saudi Arabs: a study of 270 subjects. Ann Intern Med.
1978;88(1):1-6. [DOI] [PMID] [Google Scholar]
17. Alabid T, Kordofani AA, Atalla B, Babekir A, Elamin BK. Evaluation of clinical severity of sickle cell anemia in Sudanese patients. Am J Res Commun. 2016;4:63-75. [View at Publisher] [Google Scholar]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Contact us
Tel & Fax: (+98) 17-32450093
E-mail:
goums.ac.ir
yahoo.com